ArticleOncoimmunology2021

Development of bispecific anti-c-Met/PD-1 diabodies for the treatment of solid tumors and the effect of c-Met binding affinity on efficacy.

Qingyun Yuan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.